Merck withdraws European filing for Erbitux in NSCLC
18 September 2012 | By Merck
“We are disappointed that we have not been able to move forward with the filing..."
List view / Grid view
18 September 2012 | By Merck
“We are disappointed that we have not been able to move forward with the filing..."
18 September 2012 | By B&W Tek Inc
B&W Tek, Inc. is proud to announce the expansion of their Exemplar® smart spectrometer platform.
17 September 2012 | By Gerresheimer Group
The healthcare sector needs innovative packaging solutions. Gerresheimer’s comprehensive portfolio of products extends...
17 September 2012 | By GlaxoSmithKline
GSK has submitted a regulatory application in the European Union seeking approval of an additional indication for Synflorix™...
17 September 2012 | By Pfizer
14 abstracts for tofacitinib...
17 September 2012 | By BASF
Visit us at CPhI worldwide Oct. 9-11, 2012 Hall 4, Booth 4D17 Feria de Madrid, Spain...
14 September 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has announced the beta launch of its first social game on Facebook...
14 September 2012 | By Eisai
Fycompa (Perampanel) is the first anti-epileptic drug to target AMPA receptors in the brain...
13 September 2012 | By Roche
Roche has been recognised as the most sustainable healthcare company...
13 September 2012 | By Merck
Report shows progress in the Company's four priority areas...
13 September 2012 | By GlaxoSmithKline
GlaxoSmithKline has acquired five million newly issued shares of Response Genetics Inc...
12 September 2012 | By Gerresheimer AG
Gerresheimer Medical Plastic Systems Dongguan Co. is an FDA-inspected medical device...
12 September 2012 | By Sanofi
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...
12 September 2012 | By Pfizer
Pfizer Inc. and Zhejiang Hisun Pharmaceuticals announced the launch of Hisun-Pfizer Pharmaceuticals Co., Ltd...
12 September 2012 | By Boehringer Ingelheim
New findings presented at the 2nd Asia Pacific Stroke Conference...